Manufacturing & Distribution Are Third Parties Pharmaceutical Companies’ Achilles’ Heel? Keith Kawashima February 24, 2023 Keith KawashimaAugust 16, 2021
Financial ServicesRisk Management Proposed U.S. Interagency Guidance on Third-Party Relationships: Leveling the Playing Field for Third-Party Risk Management Requirements The Protiviti View February 24, 2023 The Protiviti ViewJuly 20, 2021
Regulatory ComplianceRisk ManagementTechnology and Cyber Security Effective Third-Party Risk Management During COVID-19 and Beyond Paul Kooney and Brian Kostek February 20, 2023 Paul KooneyBrian KostekJuly 2, 2020
Keith Kawashima
The Protiviti View
Paul Kooney
Brian Kostek